BioSpace News Archive

On November 21, 2022, Agilex Biolabs was named this year’s winner for the Editor’s Choice Award for “Top company in clinical research-based development”

Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic services for biomedical research institutions and biotechnological and pharmaceutical companies.

A U.S. study of BoneView by GLEAMER AI software led by Ali Guermazi, MD, PhD, Chief of Radiology at VA Boston Healthcare System and Professor of Radiology and Medicine at Boston University School of Medicine, has been honored with the 2022 Alexander R.

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases, announced that Lyn Baranowski and Marc Schneebaum, Avalyn Pharma’s chief executive and chief financial officers will participate in the 5th Annual Evercore ISI HealthCONx Conference being held virtually November 29 – December 1, 2022.

Apobiologix, a division of Apotex Inc., expanded its product portfolio with the launch of a pre-filled autoinjector for Lapelga®, the company’s biosimilar pegfilgrastim that launched in Canada in 2019.

The global acute care telemedicine market was surpassed at USD 17.62 billion in 2021 and is expected to hit around USD 60.34 billion by 2030, growing at a CAGR of 14.66% from 2022 to 2030.

The global microbiome sequencing outsourcing services market is expected to register significant growth over the forecast period. Microbiomes are microorganisms living in the human body.

The global minimal residual disease testing market was valued at USD 1.09 billion in 2021 and it is predicted to surpass around USD 3.70 billion by 2030 with a CAGR of 14.53% from 2022 to 2030.

The global In Vitro Diagnostics (IVD) market size was USD 98.00 Billion in 2021 and is expected to register a revenue CAGR of 2.3% during the forecast period.

Industry Insights The global market for rare disease clinical trials is anticipated to register significant growth over the forecast period.